Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AJH801 Phase III Study in Essential Hypertension
jRCT2080221447Phase 3
- Sponsor
- Ajinomoto
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cilnidipine + valsartan in essential hypertension (3 arms), sponsored by Ajinomoto.
02
Drugs
cilnidipine + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080221447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221447.